The role of positive information provision in open‐label placebo

No open-label placebo effect in insomnia? Lessons learned from an experimental trial - ScienceDirect

The placebo response in medicine: minimize, maximize or personalize?

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open- label randomised trial - The Lancet

Open-Label Placebo Treatment: Outcome Expectations and General Acceptance in the Lay Population

ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension - The Lancet Gastroenterology & Hepatology

Frontiers Can the Open Label Placebo Rationale Be Optimized?

Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial - eBioMedicine

Evidencing general acceptability of open-label placebo use for tackling overtreatment in primary care: a mixed methods study, BMC Medicine

Open-Label Placebo Treatment: Outcome Expectations and General Acceptance in the Lay Population

The Placebo Response and Healthcare — Richard Lebert Registered Massage Therapy

Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU

Medicines, Free Full-Text

Change in pain expectations but no open‐label placebo analgesia: An experimental study using the heat pain paradigm - Friehs - European Journal of Pain - Wiley Online Library

Internet-based self-help randomized trial for motor functional neurologic disorder (SHIFT)

Expected Open-Label Placebo Effects